[Severe thrombocytopenia and mild leucopenia associated with deferasirox therapy]

Therapie. 2009 Nov-Dec;64(6):405-7. doi: 10.2515/therapie/2009059.

[Article in French]

Authors

Aurélie Grandvuillemin, Sylvain Audia, Vanessa Leguy-Seguin, Valérie Coullet, Bernard Bonnotte, Catherine Sgro

PMID: 20180300
DOI: 10.2515/therapie/2009059

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anemia, Sideroblastic / complications
Anemia, Sideroblastic / drug therapy
Benzoates / adverse effects*
Benzoates / therapeutic use
Chelating Agents / adverse effects*
Chelating Agents / therapeutic use
Deferasirox
Humans
Leukocyte Count
Leukopenia / blood
Leukopenia / chemically induced*
Leukopenia / therapy
Male
Middle Aged
Platelet Count
Platelet Transfusion
Thrombocytopenia / blood
Thrombocytopenia / chemically induced*
Thrombocytopenia / therapy
Triazoles / adverse effects*
Triazoles / therapeutic use

Substances

Benzoates
Chelating Agents
Triazoles
Deferasirox